Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2015-08-28 Interim / Quarterly Rep…
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
2015年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '2015 年半年度报告' which translates to '2015 Semi-Annual Report'. It contains detailed financial data, accounting data, financial indicators, management discussion and analysis, investment status, fundraising usage, and other comprehensive financial and operational information for the first half of 2015 (January to June). The document length is about 15,000 characters, indicating a full report rather than a brief announcement. The content includes actual financial statements and substantive financial data and analysis, not just references or certifications. The report is explicitly described as a half-year report (semi-annual report), which corresponds to an Interim / Quarterly Report (IR) filing type. Therefore, the document should be classified as an Interim / Quarterly Report (IR). H1 2015
2015-08-28 Chinese
2015年第二次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, and legality of a company's 2015 second extraordinary shareholders' meeting. It details the notice, attendance, voting procedures, and results of the shareholders' meeting. The document does not contain financial statements or financial performance data, nor is it a report of financial results or management discussion. It is not an announcement of voting results but a legal opinion on the meeting's compliance and validity. Given the content and nature, this document fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it relates to the shareholders' meeting and its voting process and results.
2015-08-28 Chinese
第八届监事会第七次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Zhongyuan Xiehe Cell Gene Engineering Co., Ltd. regarding the approval of the company's 2015 semi-annual report and a special report on the use of raised funds. The document states that the Supervisory Board has reviewed and approved the 2015 semi-annual report but does not contain the report itself; instead, it refers readers to the Shanghai Stock Exchange website for the full report. The document is short (927 characters) and serves as an official announcement of the Supervisory Board's meeting resolutions rather than the report itself. According to the 'Menu vs Meal' rule, this is a Regulatory Filing (RNS) because it announces the approval and existence of the report but does not include substantive financial data or the report content itself.
2015-08-28 Chinese
第八届董事会第二十八次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a board meeting resolution announcement from 中源协和细胞基因工程股份有限公司 regarding the approval of the company's 2015 semi-annual report and a special report on the use of raised funds. The document includes voting results and mentions that the full semi-annual report is available on the Shanghai Stock Exchange website, indicating that this document itself is not the full semi-annual report but an announcement of the board's approval of it. The document length is short (788 characters), and it primarily serves as a formal announcement of the board meeting decisions rather than containing substantive financial data or the full report. Therefore, according to the MENU VS MEAL RULE, this document should be classified as a Regulatory Filing (RNS) rather than an Interim/Quarterly Report (IR) or Annual Report (10-K).
2015-08-28 Chinese
重大资产重组进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company regarding the progress of a major asset restructuring (重大资产重组进展公告). It discusses the company's stock suspension due to the ongoing major asset restructuring, details about the restructuring plan, involved parties, and risks. The document is relatively short (1164 characters) and serves as an update on the progress of a transaction rather than a full financial report or detailed filing. It does not contain financial statements or detailed financial analysis. This type of announcement fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including major asset restructurings.
2015-08-25 Chinese
关于召开2015年第二次临时股东大会的提示性公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed announcement about the convening of the 2015 second extraordinary general meeting of shareholders for Zhongyuan Xiehe Cell Gene Engineering Co., Ltd. It includes information about the meeting date, voting methods, agenda items, voting procedures, and proxy authorization. There is no financial data or report content, but rather a notice and instructions related to the shareholder meeting. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which are materials sent to shareholders to provide information and request votes for meetings. The document length is 3152 characters, which is consistent with a detailed meeting notice rather than a full report. Therefore, the correct classification is PSI.
2015-08-24 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.